Alhambra Investment Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $317K | Hold |
782
| – | – | 0.16% | 134 |
|
|
2025
Q1 | $389K | Sell |
782
-20
| -2% | -$9.95K | 0.2% | 108 |
|
|
2024
Q4 | $417K | Hold |
802
| – | – | 0.21% | 102 |
|
|
2024
Q3 | $496K | Sell |
802
-20
| -2% | -$12.4K | 0.26% | 101 |
|
|
2024
Q2 | $455K | Sell |
822
-32
| -4% | -$17.7K | 0.25% | 101 |
|
|
2024
Q1 | $496K | Hold |
854
| – | – | 0.27% | 96 |
|
|
2023
Q4 | $453K | Hold |
854
| – | – | 0.27% | 102 |
|
|
2023
Q3 | $432K | Sell |
854
-21
| -2% | -$10.6K | 0.28% | 99 |
|
|
2023
Q2 | $457K | Hold |
875
| – | – | 0.3% | 92 |
|
|
2023
Q1 | $504K | Hold |
875
| – | – | 0.35% | 79 |
|
|
2022
Q4 | $482K | Hold |
875
| – | – | 0.35% | 78 |
|
|
2022
Q3 | $444K | Sell |
875
-25
| -3% | -$12.7K | 0.34% | 80 |
|
|
2022
Q2 | $489K | Sell |
900
-25
| -3% | -$13.6K | 0.35% | 81 |
|
|
2022
Q1 | $546K | Buy |
925
+3
| +0.3% | +$1.77K | 0.36% | 80 |
|
|
2021
Q4 | $615K | Sell |
922
-25
| -3% | -$16.7K | 0.43% | 75 |
|
|
2021
Q3 | $541K | Hold |
947
| – | – | 0.41% | 80 |
|
|
2021
Q2 | $478K | Buy |
947
+43
| +5% | +$21.7K | 0.36% | 86 |
|
|
2021
Q1 | $413K | Sell |
904
-93
| -9% | -$42.5K | 0.33% | 95 |
|
|
2020
Q4 | $464K | Sell |
997
-65
| -6% | -$30.3K | 0.49% | 67 |
|
|
2020
Q3 | $469K | Sell |
1,062
-11
| -1% | -$4.86K | 0.56% | 57 |
|
|
2020
Q2 | $389K | Sell |
1,073
-17
| -2% | -$6.16K | 0.51% | 56 |
|
|
2020
Q1 | $309K | Buy |
1,090
+15
| +1% | +$4.25K | 0.51% | 56 |
|
|
2019
Q4 | $349K | Buy |
+1,075
| New | +$349K | 0.4% | 76 |
|